These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. Regl G; Neill GW; Eichberger T; Kasper M; Ikram MS; Koller J; Hintner H; Quinn AG; Frischauf AM; Aberger F Oncogene; 2002 Aug; 21(36):5529-39. PubMed ID: 12165851 [TBL] [Abstract][Full Text] [Related]
5. GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. Ikram MS; Neill GW; Regl G; Eichberger T; Frischauf AM; Aberger F; Quinn A; Philpott M J Invest Dermatol; 2004 Jun; 122(6):1503-9. PubMed ID: 15175043 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas. Tang JY; Xiao TZ; Oda Y; Chang KS; Shpall E; Wu A; So PL; Hebert J; Bikle D; Epstein EH Cancer Prev Res (Phila); 2011 May; 4(5):744-51. PubMed ID: 21436386 [TBL] [Abstract][Full Text] [Related]
7. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067 [TBL] [Abstract][Full Text] [Related]
8. GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells. Eichberger T; Kaser A; Pixner C; Schmid C; Klingler S; Winklmayr M; Hauser-Kronberger C; Aberger F; Frischauf AM J Biol Chem; 2008 May; 283(18):12426-37. PubMed ID: 18319260 [TBL] [Abstract][Full Text] [Related]
9. Distinct cellular origin and genetic requirement of Hedgehog-Gli in postnatal rhabdomyosarcoma genesis. Rajurkar M; Huang H; Cotton JL; Brooks JK; Sicklick J; McMahon AP; Mao J Oncogene; 2014 Nov; 33(46):5370-8. PubMed ID: 24276242 [TBL] [Abstract][Full Text] [Related]
10. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma. Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206 [TBL] [Abstract][Full Text] [Related]
11. Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. Neill GW; Ghali LR; Green JL; Ikram MS; Philpott MP; Quinn AG Cancer Res; 2003 Aug; 63(15):4692-7. PubMed ID: 12907651 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Canettieri G; Di Marcotullio L; Greco A; Coni S; Antonucci L; Infante P; Pietrosanti L; De Smaele E; Ferretti E; Miele E; Pelloni M; De Simone G; Pedone EM; Gallinari P; Giorgi A; Steinkühler C; Vitagliano L; Pedone C; Schinin ME; Screpanti I; Gulino A Nat Cell Biol; 2010 Feb; 12(2):132-42. PubMed ID: 20081843 [TBL] [Abstract][Full Text] [Related]
13. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Regl G; Kasper M; Schnidar H; Eichberger T; Neill GW; Philpott MP; Esterbauer H; Hauser-Kronberger C; Frischauf AM; Aberger F Cancer Res; 2004 Nov; 64(21):7724-31. PubMed ID: 15520176 [TBL] [Abstract][Full Text] [Related]
14. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas. Atwood SX; Li M; Lee A; Tang JY; Oro AE Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420 [TBL] [Abstract][Full Text] [Related]
15. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437 [TBL] [Abstract][Full Text] [Related]
16. Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Eichberger T; Sander V; Schnidar H; Regl G; Kasper M; Schmid C; Plamberger S; Kaser A; Aberger F; Frischauf AM Genomics; 2006 May; 87(5):616-32. PubMed ID: 16434164 [TBL] [Abstract][Full Text] [Related]
17. Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors. Wendling DS; Lück C; von Schweinitz D; Kappler R Int J Mol Med; 2008 Dec; 22(6):787-92. PubMed ID: 19020777 [TBL] [Abstract][Full Text] [Related]
18. Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma. Ning H; Mitsui H; Wang CQ; Suárez-Fariñas M; Gonzalez J; Shah KR; Chen J; Coats I; Felsen D; Carucci JA; Krueger JG Oncotarget; 2013 Dec; 4(12):2237-48. PubMed ID: 24163262 [TBL] [Abstract][Full Text] [Related]